TXNIP and neoplasm: Consistent with the initial inhibitory events, knocking down CAST in TXNIP-OE HCC-1954 cells led to a significant reduction in cell proliferation, colony formation, and tumor growth in a mouse xenograft model (Fig. 4C–F).